Hexagon Bio, Inc.
Hexagon Bio is a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome. Leveraging a proprietary platform that combines data science, genomics, synthetic biology, and automation, the company mines microbial genomes for novel small molecules and their protein targets to develop therapeutics for human diseases, especially in oncology and infectious diseases. The company is advancing a pipeline of next-generation antibody-drug conjugates (ADCs) with novel payloads designed to address significant unmet needs in cancer treatment.
Industries
Nr. of Employees
medium (51-250)
Products
Preclinical ADC candidates using novel natural-product-derived payloads
A pipeline of preclinical antibody-drug conjugate (ADC) candidates that use small-molecule payloads discovered from microbial genomes, including payloads that inhibit protein translation and payloads with mechanisms orthogonal to existing ADC payloads.
Preclinical ADC candidates using novel natural-product-derived payloads
A pipeline of preclinical antibody-drug conjugate (ADC) candidates that use small-molecule payloads discovered from microbial genomes, including payloads that inhibit protein translation and payloads with mechanisms orthogonal to existing ADC payloads.
Services
Collaborative drug-discovery partnerships
Collaborative research partnerships to apply the company's platform (genomics, computation, synthetic biology, chemistry, automation) to discover and develop natural-product-derived small molecules.
Collaborative drug-discovery partnerships
Collaborative research partnerships to apply the company's platform (genomics, computation, synthetic biology, chemistry, automation) to discover and develop natural-product-derived small molecules.
Expertise Areas
- Metagenomic drug discovery
- Antibody-drug conjugate payload discovery
- Computational genomics and bioinformatics
- Machine learning for natural-product discovery
Key Technologies
- Next-generation sequencing
- Machine learning for bioinformatics
- Heterologous expression systems
- Synthetic biology